Probiotics and prebiotics in neonatal necrotizing enterocolitis: New opportunities for translational research

Pathophysiology

Volumn 21, Issue 1, 2014, Pages 35-46

  Panigrahi, Pinaki ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Gut immunology; Gut microbiota; Mathematical modeling; Neonatal necrotizing enterocolitis; Non invasive technology; Prebiotics; Prematurity; Probiotics; Synbiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIFIDOBACTERIACEAE; DRUG EFFICACY; ESCHERICHIA COLI; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOMODULATION; INCIDENCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; KLEBSIELLA; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BULGARICUS; MATHEMATICAL MODEL; NECROTIZING ENTEROCOLITIS; NEWBORN DISEASE; NEWBORN NECROTIZING ENTEROCOLITIS; NON INVASIVE PROCEDURE; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PATHOPHYSIOLOGY; PREMATURITY; PRIORITY JOURNAL; QUORUM SENSING; RISK FACTOR; VASCULAR RESISTANCE;

EID: 84896079644     PISSN: 09284680     EISSN: 1873149X     Source Type: Journal    
DOI: 10.1016/j.pathophys.2013.11.016     Document Type: Article

References (123)

1. Bisquera J.A., Cooper T.R., Berseth C.L. Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants. Pediatrics 2002, 109(March (3)):423-428.
2. Generisch A. Bauchfellentzundung beim neugeborenen in folge von perforation des ileums. Virchows Arch. Pathol. Anat. 1891, 126:485.
3. Paltauf A. Die spontane dickdarm ruptur der neugeborenen. Virchows Arch. Pathol. 1888, 111:461.
4. Santulli T.V., Schullinger J.N., Heird W.C., et al. Acute necrotizing enterocolitis in infancy: a review of 64 cases. Pediatrics 1975, 55(3):376-387.
5. Panigrahi P. Necrotizing enterocolitis: a practical guide to its prevention and management. Paediatr. Drugs 2006, 8(3):151-165.
6. Edelman J. The formation of oligosaccharides by enzymic transglycosylation. Adv. Enzymol. Relat. Subj. Biochem. 1956, 17:189-232.
7. Edelman J., Jefford T.G. The metabolism of fructose polymers in plants. 4. Beta-fructofuranosidases of tubers of Helianthus tuberosus L. Biochem. J. 1964, 93(October (1)):148-161.
8. Baird I.M., Walters R.L., Davies P.S., Hill M.J., Drasar B.S., Southgate D.A. The effects of two dietary fiber supplements on gastrointestinal transit, stool weight and frequency, and bacterial flora, and fecal bile acids in normal subjects. Metabolism 1977, 26(February (2)):117-128.
9. Drasar B.S., Jenkins D.J., Cummings J.H. The influence of a diet rich in wheat fibre on the human faecal flora. J. Med. Microbiol. 1976, 9(November (4)):423-431.
10. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 1995, 125(June (6)):1401-1412.
11. Roberfroid M. Prebiotics: the concept revisited. J. Nutr. 2007, 137(March (3 Suppl. 2)):830S-837S. Review, PMID: 17311983.
12. Srinivasjois R., Rao S., Patole S. Prebiotic supplementation in preterm neonates: updated systematic review and meta-analysis of randomised controlled trials. Clin. Nutr. 2013, pii: S0261-5614(13)00148-9.
13. Mizzahi A., Barlow O., Berdon W., et al. Necrotizing enterocolitis in premature infants. J. Pediatr. 1965, 66:697-705. 336(8730):1519-1523.
14. Wilson R., Kanto W., McCarthy B.J., et al. Epidemiologic characteristics of necrotizing enterocolitis: a population-based study. Am. J. Epidemiol. 1981, 114.
15. Uauy R.D., Fanaroff A., Korones S.B., et al. Necrotizing enterocolitis in very low birthweight infants: biodemographics and clinical correlates. J. Pediatr. 1991, 119:630-638.
16. Stoll B.J., Kanto W.P., Glass R.I., et al. Epidemiology of necrotizing enterocolitis: a case control study. Pediatrics 1980, 96:447-451.
17. Kliegman R.M., Walker W.A., Yolken R.H. Necrotizing enterocolitis: research agenda for a disease of unknown etiology and pathogenesis. Pediatr. Res. 1993, 34(6):701-708.
18. Horbar J.D., Badger G.J., Carpenter J.H., Fanaroff A.A., Kilpatrick S., LaCorte M., Phibbs R., Soll R.F., Members of the Vermont Oxford Network Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 2002, 110:143-151.
19. Holman R.C., Stoll B.J., Curns A.T., Yorita K.L., Steiner C.A., Schonberger L.B. Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr. Perinat. Epidemiol. 2006, 20(November (6)):498-506. PMID: 17052286.
20. Grave G.D., Nelson S.A., Walker W.A., Moss R.L., Dvorak B., Hamilton F.A., Higgins R., Raju T.N. New therapies and preventive approaches for necrotizing enterocolitis: report of a research planning workshop. Pediatr. Res. 2007, 62(October (4)):510-514.
21. Touloukian R.J., Berdon W.E., Amoury R.A., et al. Surgical experience with necrotizing enterocolitis in the infant. J. Pediatr. Surg. 1967, 2:389-401.
22. Lloyd J. The etiology of gastrointestinal perforations in the newborn. J. Pediatr. Surg. 1969, 4:77-84.
23. Herbst J.J., Koldovský O. Cell migration and cortisone induction of sucrose activity in jejunum and ileum. Biochem. J. 1972, 126(February (3)):471-476.
24. Granger H., Nyhof R.A. Dynamics of intestinal oxygenation: interactions between oxygen supply and uptake. Am. J. Physiol. 1982, 243:G91-G96.
25. Shepherd A., Granger J. Autoregulatory escape in the gut: a systems analysis. Gastroenterology 1973, 65:77-91.
26. 2 consumption in necrotizing enterocolitis: role of nitric oxide. Pediatr. Res. 2006, 59:500-505.
27. Nowicki P.T., Dunaway D.J., Nankervis C.A., Giannone P.J., Reber K.M., Hammond S.B., Besner G.E., Caniano D.A. Endothelin-1 in human intestine resected for necrotizing enterocolitis. J. Pediatr. 2005, 146(June (6)):805-810.
28. Ganguli K., Walker W.A. Probiotics in the prevention of necrotizing enterocolitis. J. Clin. Gastroenterol. 2011, 45(November (Suppl.)):S133-S138.
29. Long S.S., Swenson R.M. Development of anaerobic fecal flora in healthy newborn infants. J. Pediatr. 1977, 91(August (2)):298-301.
30. Gewolb I.H., Schwalbe R.S., Taciak V.L., Harrison T.S., Panigrahi P. Stool microflora in extremely low birthweight infants. Arch. Dis. Childhood 1999, 80:167-173.
31. Gupta S., Morris J.G., Panigrahi P., Natero J., Glass R.I., Gewolb I.H. Molecular epidemiology of endemic necrotizing enterocolitis in a university hospital: lack of association of NEC with a specific infectious agent. Pediatr. Infect. Dis. J. 1994, 13(8):728-734.
32. Panigrahi P., Gupta S., Gewolb I.H., Morris J.G. Occurrence of necrotizing enterocolitis may be dependent on patterns of bacterial adherence and intestinal colonization: studies in Caco-2 tissue culture and weanling rabbit models. Pediatr. Res. 1994, 36(1):115-121.
33. Millar M.R., Linton C.J., Cade A., Glancy D., Hall M., Jalal H. Application of 16S rRNA gene PCR to study bowel flora of preterm infants with and without necrotizing enterocolitis. J. Clin. Microbiol. 1996, 34(October (10)):2506-2510.
34. Wang Y., Hoenig J.D., Malin K.J., Qamar S., Petrof E.O., Sun J., Antonopoulos D.A., Chang E.B., Claud E.C. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 2009, 3(August (8)):944-954.
35. Nanthakumar N., Meng D., Goldstein A.M., Zhu W., Lu L., Uauy R., Llanos A., Claud E.C., Walker W.A. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLOS ONE 2011, 6(March (3)).
36. Martin C.R., Walker W.A. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin. Perinatol. 2008, 32(April (2)):127-137.
37. Deplancke B., Gaskins H.R. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am. J. Clin. Nutr. 2001, 73(June (6)):1131S-1141S.
38. Campeau J.L., Salim S.Y., Albert E.J., Hotte N., Madsen K.L. Intestinal epithelial cells modulate antigen-presenting cell responses to bacterial DNA. Infect. Immun. 2012, 80(August (8)):2632-2644.
39. Kennedy R.J., Kirk S.J., Gardiner K.R. Mucosal barrier function and the commensal flora. Gut 2002, 50(March (3)):441-442.
40. Stratiki Z., Costalos C., Sevastiadou S., Kastanidou O., Skouroliakou M., Giakoumatou A., Petrohilou V. The effect of a Bifidobacter supplemented bovinemilk on intestinal permeability of preterm infants. Early Hum. Dev. 2007, 83(September (9)):575-579.
41. Li N., Russell W.M., Douglas-escobar M., Hauser N., Lopez M., Neu J. Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr. Res. 2009, 66(August (2)):203-207.
42. Petrof E.O. Probiotics and gastrointestinal disease: clinical evidence and basic science. Antiinflamm. Antiallergy Agents Med. Chem. 2009, 8(September (3)):260-269.
43. Lin H.C., Su B.H., Chen A.C., Lin T.W., Tsai C.H., Yeh T.F., Oh W. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005, 115(January (1)):1-4.
44. Lin H.C., Hsu C.H., Chen H.L., Chung M.Y., Hsu J.F., Lien R.I., Tsao L.Y., Chen C.H., Su B.H. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008, 122(October (4)):693-700.
45. Beerens H., Romond C., Neut C. Influence of breast-feeding on the bifid flora of the newborn intestine. Am. J. Clin. Nutr. 1980, 33(November (11 Suppl.)):2434-2439.
46. Pedreschi R., Campos D., Noratto G., Chirinos R., Cisneros-Zevallos L. Andean yacon root (Smallanthus sonchifolius Poepp. Endl) fructooligosaccharides as a potential novel source of prebiotics. J. Agric. Food Chem. 2003, 51(August (18)):5278-5284.
47. Kruse H.P., Kleessen B., Blaut M. Effects of inulin on faecal bifidobacteria in human subjects. Br. J. Nutr. 1999, 82(November (5)):375-382.
48. Cummings J.H., Macfarlane G.T. Gastrointestinal effects of prebiotics. Br. J. Nutr. 2002, 87(May (Suppl. 2)):S145-S151.
49. Boehm G., Lidestri M., Casetta P., Jelinek J., Negretti F., Stahl B., Marini A. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch. Dis. Child Fetal Neonatal Ed. 2002, 86(May (3)):F178-F181.
50. Mihatsch W.A., Hoegel J., Pohlandt F. Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants. Acta Paediatr. 2006, 95(July (7)):843-848.
51. Kapiki A., Costalos C., Oikonomidou C., Triantafyllidou A., Loukatou E., Pertrohilou V. The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Early Hum. Dev. 2007, 83(May (5)):335-339.
52. Riskin A., Hochwald O., Bader D., Srugo I., Naftali G., Kugelman A., Cohen E., Mor F., Kaufman B., Shaoul R. The effects of lactulose supplementation to enteral feedings in premature infants: a pilot study. J. Pediatr. 2010, 156(February (2)):209-214.
53. Indrio F., Riezzo G., Raimondi F., Bisceglia M., Cavallo L., Francavilla R. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J. Pediatr. 2008, 152(June (6)):801-806.
54. Westerbeek E.A., van Elburg R.M., van den Berg A., van den Berg J., Twisk J.W., Fetter W.P., Lafeber H.N. Design of a randomised controlled trial on immune effects of acidic and neutral oligosaccharides in the nutrition of preterm infants: carrot study. BMC Pediatr. 2008, 8:46.
55. Modi N., Uthaya S., Fell J., Kulinskaya E. A randomized, double-blind, controlled trial of the effect of prebiotic oligosaccharides on enteral tolerance in preterm infants (ISRCTN77444690). Pediatr. Res. 2010, 68(November (5)):440-445.
56. Fernández-Carrocera L.A., Solis-Herrera A., Cabanillas-Ayón M., Gallardo-Sarmiento R.B., García-Pérez C.S., Montaño-Rodríguez R., Echániz-Aviles M.O. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500g in the prevention of necrotizing enterocolitis. Arch. Dis. Child Fetal Neonatal Ed. 2013, 98(January (1)):F5-F9. PMID: 22556209. 10.1136/archdischild-2011-300435.
57. Al-Hosni M., Duenas M., Hawk M., Stewart L.A., Borghese R.A., Cahoon M., Atwood L., Howard D., Ferrelli K., Soll R. Probiotics-supplemented feeding in extremely low-birth-weight infants. J. Perinatol. 2012, 32(April (4)):253-259.
58. Manzoni P., Lista G., Gallo E., Marangione P., Priolo C., Fontana P., Guardione R., Farina D. Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study. Early Hum. Dev. 2011, 87(March (Suppl. 1)):S35-S38. 10.1016/j.earlhumdev.2011.01.036.
59. Sari F.N., Dizdar E.A., Oguz S., Erdeve O., Uras N., Dilmen U. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur. J. Clin. Nutr. 2011, 65(April (4)):434-439.
60. Braga T.D., da Silva G.A., de Lira P.I., de Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am. J. Clin. Nutr. 2011, 93(January (1)):81-86.
61. Awad H., Mokhtar H., Imam S.S., Gad G.I., Hafez H., Aboushady N. Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates. Pak. J. Biol. Sci. 2010, 13(March (6)):253-262.
62. Mihatsch W.A., Vossbeck S., Eikmanns B., Hoegel J., Pohlandt F. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology 2010, 98(2):156-163.
63. Bin-Nun A., Bromiker R., Wilschanski M., Kaplan M., Rudensky B., Caplan M., Hammerman C. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J. Pediatr. 2005, 147(August (2)):192-196.
64. Dani C., Biadaioli R., Bertini G., Martelli E., Rubaltelli F.F. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol. Neonate 2002, 82(August (2)):103-108.
65. Hoyos A.B. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int. J. Infect. Dis. 1999, 3(4):197-202.
66. Wang Q., Dong J., Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J. Pediatr. Surg. 2012, 47(January (1)):241-248.
67. Samanta M., Sarkar M., Ghosh P., et al. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J. Trop. Pediatr. 2009, 55:128-131.
68. Szajewska H., Guandalini S., Morelli L., Van Goudoever J.B., Walker A. Effect of Bifidobacterium animalis subsp. lactis supplementation in preterm infants: a systematic review of randomized controlled trials. J. Pediatr. Gastroenterol. Nutr. 2010, 51(August (2)):203-209. PMID: 20543719. 10.1097/MPG.0b013e3181dc0d93.
69. Deshpande G., Rao S., Patole S., Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010, 125(May (5)):921-930. 10.1542/peds.2009-1301.
70. Alfaleh K., Anabrees J., Bassler D. Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis. Neonatology 2010, 97(2):93-99.
71. Srinivasjois R., Rao S., Patole S. Prebiotic supplementation of formula in preterm neonates: a systematic review and meta-analysis of randomised controlled trials. Clin. Nutr. 2009, 28(June (3)):237-242.
72. Alfaleh K., Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst. Rev. 2008, (1):CD005496. Review, update in: Cochrane Database Syst. Rev. 2011;(3):CD005496, PMID: 18254081. 10.1002/14651858.CD005496.pub2.
73. Mugambi M.N., Musekiwa A., Lombard M., Young T., Blaauw R. Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review. Nutr. J. 2012, 11:58. 10.1186/1475-2891-11-58.
74. Wang Q., Dong J., Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J. Pediatr. Surg. 2012, 47(January (1)):241-248. PMID: 22244424. 10.1016/j.jpedsurg.2011.09.064.
75. Mihatsch W.A., Braegger C.P., Decsi T., Kolacek S., Lanzinger H., Mayer B., Moreno L.A., Pohlandt F., Puntis J., Shamir R., Stadtmüller U., Szajewska H., Turck D., van Goudoever J.B. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin. Nutr. 2012, 31(February (1)):6-15.
76. Mihatsch W.A. What is the power of evidence recommending routine probiotics for necrotizing enterocolitis prevention in preterm infants?. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14(May (3)):302-306.
77. Szajewska H., Guandalini S., Morelli L., Van Goudoever J.B., Walker A. Effect of Bifidobacterium animalis subsp. lactis supplementation in preterm infants: a systematic review of randomized controlled trials. J. Pediatr. Gastroenterol. Nutr. 2010, 51(August (2)):203-209.
78. Barclay A.R., Stenson B., Simpson J.H., Weaver L.T., Wilson D.C. Probiotics for necrotizing enterocolitis: a systematic review. J. Pediatr. Gastroenterol. Nutr. 2007, 45(November (5)):569-576.
79. Claud E.C. Probiotics and neonatal necrotizing enterocolitis. Anaerobe 2011, 17:180-185.
80. Egger M., Smith D.G., Schneider M., Minder C. Bias in meta-analysis detected by simple graphical test. BMJ 1997, 315(7109):629-634.
81. Wu S.F., Chiu H.Y., Chen A.C., Lin H.Y., Lin H.C., Caplan M. Efficacy of different probiotic combinations on death and necrotizing enterocolitis in a premature rat model. J. Pediatr. Gastroenterol. Nutr. 2013, 57(July (1)):23-28.
82. Wickens K., Black P.N., Stanley T.V., Mitchell E., Fitzharris P., Tannock G.W., Purdie G., Crane J., Probiotic Study Group A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2008, 122(October (4)):788-794.
83. Canani R.B., Cirillo P., Terrin G., Cesarano L., Spagnuolo M.I., De Vincenzo A., Albano F., Passariello A., De Marco G., Manguso F., Guarino A. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 2007, 335(August (7615)):340.
84. de Roock S., van Elk M., Hoekstra M.O., Prakken B.J., Rijkers G.T., de Kleer I.M. Gut derived lactic acid bacteria induce strain specific CD4(+) T cell responses in human PBMC. Clin. Nutr. 2011, 30(December (6)):845-851.
85. LaSarre B., Federle M.J. Exploiting quorum sensing to confuse bacterial pathogens. Microbiol. Mol. Biol. Rev. 2013, 77(March (1)):73-111.
86. Rutherford S.T., Bassler B.L. Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb. Perspect. Med. 2012, 2(11).
87. Shenderov B.A. Probiotic (symbiotic) bacterial languages. Anaerobe 2011, 17(December (6)):490-495.
88. Chu W., Lu F., Zhu W., Kang C. Isolation and characterization of new potential probiotic bacteria based on quorum-sensing system. J. Appl. Microbiol. 2011, 110(January (1)):202-208.
89. Di Cagno R., De Angelis M., Calasso M., Gobbetti M. Proteomics of the bacterial cross-talk by quorum sensing. J. Proteomics 2011, 74(January (1)):19-34.
90. Ditu L.M., Chifiriuc M.C., Bezirtzoglou E., Voltsi C., Bleotu C., Pelinescu D., Mihaescu G., Lazar V. Modulation of virulence and antibiotic susceptibility of enteropathogenic Escherichia coli strains by Enterococcus faecium probiotic strain culture fractions. Anaerobe 2011, 17(December (6)):448-451.
91. Lazar V., Miyazaki Y., Hanawa T., Chifiriuc M.C., Ditu L.M., Marutescu L., Bleotu C., Kamiya S. The influence of some probiotic supernatants on the growth and virulence features expression of several selected enteroaggregative E. coli clinical strains. Roum. Arch. Microbiol. Immunol. 2009, 68(October-December (4)):207-214.
92. Tabasco R., García-Cayuela T., Peláez C., Requena T. Lactobacillus acidophilus La-5 increases lactacin B production when it senses live target bacteria. Int. J. Food Microbiol. 2009, 132(June (2/3)):109-116.
93. Panigrahi P., Braileanu G.T., Chen H., Stine O.C. Probiotic bacteria change Escherichia coli-induced gene expression in cultured colonocytes: implications in intestinal pathophysiology. World J. Gastroenterol. 2007, 13(December (47)):6370-6378.
94. Goodman A.L., Kallstrom G., Faith J.J., Reyes A., Moore A., Dantas G., Gordon J.I. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(April (15)):6252-6257.
95. Hashimoto N., Ohyanagi H. Systemic factors are trophic in Thiry-Vella loop in the absence of luminal contents. Hepatogastroenterology 2002, 49(March-April (44)):428-431.
96. Gibney B.C., Chamoto K., Lee G.S., Simpson D.C., Miele L.F., Tsuda A., Konerding M.A., Wagers A., Mentzer S.J. Cross-circulation and cell distribution kinetics in parabiotic mice. J. Cell Physiol. 2012, 227(February (2)):821-828.
97. Kumagai K., Vasanji A., Drazba J.A., Butler R.S., Muschler G.F. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J. Orthop. Res. 2008, 26(February (2)):165-175.
98. Heeschen C., Chang E., Aicher A., Cooke J.P. Endothelial progenitor cells participate in nicotine-mediated angiogenesis. J. Am. Coll. Cardiol. 2006, 48(December (12)):2553-2560.
99. Faith J.J., McNulty N.P., Rey F.E., Gordon J.I. Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science 2011, 333(July (6038)):101-104.
100. Turnbaugh P.J., Ridaura V.K., Faith J.J., Rey F.E., Knight R., Gordon J.I. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009, 1(November (6)):6ra14.
101. McNulty N.P., Yatsunenko T., Hsiao A., Faith J.J., Muegge B.D., Goodman A.L., Henrissat B., Oozeer R., Cools-Portier S., Gobert G., Chervaux C., Knights D., Lozupone C.A., Knight R., Duncan A.E., Bain J.R., Muehlbauer M.J., Newgard C.B., Heath A.C., Gordon J.I. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci. Transl. Med. 2011, 3(October (106)):106ra106.
102. Catala I., Butel M.J., Bensaada M., Popot F., Tessedre A.C., Rimbault A., Szylit O. Oligofructose contributes to the protective role of bifidobacteria in experimental necrotising enterocolitis in quails. J. Med. Microbiol. 1999, 48(January (1)):89-94.
103. Freter R., Stauffer E., Cleven D., Holdeman L.V., Moore W.E. Continuous-flow cultures as in vitro models of the ecology of large intestinal flora. Infect. Immun. 1983, 39(February (2)):666-675.
104. Freter R., Brickner H., Botney M., Cleven D., Aranki A. Mechanisms that control bacterial populations in continuous-flow culture models of mouse large intestinal flora. Infect. Immun. 1983, 39(February (2)):676-685.
105. Preface: Necrotizing Enterocolitis 2000, 31-53. Medical Intelligence Unit 18, Landers Bioscience, Georgetown, TX. B.G. Gilchrist (Ed.).
106. Iyengar V., Albaugh G.P., Lohani A., Nair P.P. Human stools as a source of viable colonic epithelial cells. FASEB J. 1991, 5:2856-2859.
107. Kamra A., Kessie G., Chen J.H., Kalavapudi S., Shores R., McElroy I., Gireesh T., Sudhakaran P.R., Dutta S.K., Nair P.P. Exfoliated colonic epithelial cells: surrogate targets for evaluation of bioactive food components in cancer prevention. J. Nutr. 2005, 135(November (11)):2719-2722.
108. Yamao T., Matsumura Y., Shimada Y., Moriya Y., Sugihara K., Akasu T., Fujita S., Kakizoe T. Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer. Gastroenterology 1998, 114(June (6)):1196-1205.
109. Matsushita H., Matsumura Y., Moriya Y., Akasu T., Fujita S., Yamamoto S., Onouchi S., Saito N., Sugito M., Ito M., Kozu T., Minowa T., Nomura S., Tsunoda H., Kakizoe T. A new method for isolating colonocytes from naturally evacuated feces and its clinical application to colorectal cancer diagnosis. Gastroenterology 2005, 129(December (6)):1918-1927.
110. Kaeffer B., des Robert C., Alexandre-Gouabau M.C., Pagniez A., Legrand A., Amarger V., Küster A., Piloquet H., Champ M., le Huërou-Luron I., Rozé J.C. Recovery of exfoliated cells from the gastrointestinal tract of premature infants: a new tool to perform noninvasive biopsies?. Pediatr. Res. 2007, 62(November (5)):564-569.
111. Chandel D.S., Braileanu G.T., Chen J.H., Chen H.H., Panigrahi P. Live colonocytes in newborn stool: surrogates for evaluation of gut physiology and disease pathogenesis. Pediatr. Res. 2011, 70(August (2)):153-158.
112. Upperman J.S., Camerini V., Lugo B., Yotov I., Sullivan J., Rubin J., Clermont G., Zamora R., Ermentrout G.B., Ford H.R., Vodovotz Y. Mathematical modeling in necrotizing enterocolitis - a new look at an ongoing problem. J. Pediatr. Surg. 2007, 42(March (3)):445-453.
113. Arciero J.C., Ermentrout G.B., Upperman J.S., Vodovotz Y., Rubin J.E. Using a mathematical model to analyze the role of probiotics and inflammation in necrotizing enterocolitis. PLoS ONE 2010, 5(April (4)):e10066.
114. Kim M., Christley S., Alverdy J.C., Liu D., An G. Immature oxidative stress management as a unifying principle in the pathogenesis of necrotizing enterocolitis: insights from an agent-based model. Surg. Infect. (Larchmt) 2012, 13:18-32.
115. Arciero J., Bard Ermentrout G., Siggers R., Afrazi A., Hackam D., Vodovotz Y., Rubin J. Modeling the interactions of bacteria and Toll-like receptor-mediated inflammation in necrotizing enterocolitis. J. Theor. Biol. 2013, 321:83-99.
116. Salzman N.H., Underwood M.A., Bevins C.L. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin. Immunol. 2007, 19(April (2)):70-83.
117. Salzman N.H., Polin R.A., Harris M.C., Ruchelli E., Hebra A., Zirin-Butler S., Jawad A., Martin Porter E., Bevins C.L. Enteric defensin expression in necrotizing enterocolitis. Pediatr. Res. 1998, 44(July (1)):20-26.
118. Clevers H.C., Bevins C.L. Paneth cells: maestros of the small intestinal crypts. Annu. Rev. Physiol. 2013, 75:289-311. 10.1146/annurev-physiol-030212-183744.
119. Ma B.W., Bokulich N.A., Castillo P.A., Kananurak A., Underwood M.A., Mills D.A., Bevins C.L. Routine habitat change: a source of unrecognized transient alteration of intestinal microbiota in laboratory mice. PLOS ONE 2012, 7(10):e47416.
120. Morrow A.L., Meinzen-Derr J., Huang P., Schibler K.R., Cahill T., Keddache M., Kallapur S.G., Newburg D.S., Tabangin M., Warner B.B., Jiang X. Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants. J. Pediatr. 2011, 158(May (5)):745-751.
121. De Leoz M.L., Gaerlan S.C., Strum J.S., Dimapasoc L.M., Mirmiran M., Tancredi D.J., Smilowitz J.T., Kalanetra K.M., Mills D.A., German J.B., Lebrilla C.B., Underwood M.A. Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm. J. Proteome Res. 2012, 11(9):4662-4672.
122. D'Adamo P.J., Kelly G.S. Metabolic and immunologic consequences of ABH secretor and Lewis subtype status. Altern. Med. Rev. 2001, 6(August (4)):390-405.
123. Alaish S.M., Smith A.D., Timmons J., Greenspon J., Eyvazzadeh D., Murphy E., Shea-Donahue T., Cirimotich S., Mongodin E., Zhao A., Fasano A., Nataro J.P., Cross A. Gut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host. Gut Microbes 2013, 4(July (4)):292-305.